GlucoBerry for Blood Sugar: Who It Works For and How
TL;DR
- GlucoBerry is a blood sugar support supplement built around three clinically studied ingredients: Maqui Berry Extract (Delphinol®), Gymnema Sylvestre, and Chromium.
- Its “Blood Sugar Drain” mechanism targets the kidney’s glucose-filtering pathway — a plausible but still-emerging area of research.
- It is best suited for pre-diabetic adults (fasting glucose 100–125 mg/dL) and people with post-meal glucose spikes or sugar cravings tied to glucose dysregulation.
- People with Type 1 diabetes or medicated Type 2 diabetes should not use GlucoBerry without physician oversight — interaction risk with medications is real.
- GlucoBerry comes with a 180-day money-back guarantee, making it low-risk to trial under physician supervision.
Breadcrumb: Home › GlucoBerry for Blood Sugar
GlucoBerry may support healthy blood sugar levels in pre-diabetic adults and people with mildly dysregulated glucose — but it is not a medication, it is not appropriate for everyone, and its most-marketed mechanism (the “Blood Sugar Drain”) is only partially supported by direct human evidence. As a Registered Dietitian Nutritionist, I want to be specific about who this supplement is actually designed for, what the science says, and where the honest limits of that science are.
Check Current Pricing on the GlucoBerry Official Website{rel=“nofollow sponsored”}
1. Does GlucoBerry Work for Blood Sugar? The Direct Answer
The direct answer is: yes, for a specific population — and with realistic expectations.
GlucoBerry’s three core ingredients — Maqui Berry Extract (Delphinol®), Gymnema Sylvestre, and Chromium — each have published human clinical evidence for blood sugar support. Delphinol was tested in a peer-reviewed 120-day randomized controlled trial and showed a 5.3% reduction in fasting plasma glucose in overweight adults. Gymnema Sylvestre has been evaluated in multiple meta-analyses showing meaningful reductions in HbA1c and fasting glucose in pre-diabetic and early-stage diabetic populations. Chromium’s role as an insulin cofactor is among the most-replicated findings in nutritional science.
What GlucoBerry is not: a replacement for metformin, insulin, or any prescribed diabetes medication. It does not “cure” elevated blood sugar. It does not produce the magnitude of effect that prescription glucose-lowering drugs do. For adults who are already on glucose-lowering medications, adding GlucoBerry without physician oversight creates a real hypoglycemia risk, particularly because of Gymnema Sylvestre’s additive effect on blood-sugar-lowering mechanisms.
The population where GlucoBerry makes the most evidence-based sense: pre-diabetic adults (fasting glucose 100–125 mg/dL, HbA1c 5.7–6.4%) who are managing glucose through diet, exercise, and lifestyle — and who want an evidence-supported supplement to complement those efforts. For this group, the ingredient profile is appropriate, the risk profile is low, and the 180-day guarantee allows for a meaningful trial period.
For a broader evaluation of the product overall, see our full GlucoBerry review.
2. Understanding GlucoBerry’s Blood Sugar Drain Mechanism
GlucoBerry’s central marketing concept is what its formulator, Dr. Mark Weis of MD/Process, calls the “Blood Sugar Drain.” Understanding what this means — and where the evidence stands — requires a brief detour into renal glucose physiology.
How the Kidneys Handle Glucose
Your kidneys filter roughly 160–180 grams of glucose from your bloodstream every day. Under normal physiological conditions, nearly all of that glucose is reabsorbed back into the bloodstream through specialized transporter proteins in the kidney tubules — primarily Sodium-Glucose Cotransporter 2, or SGLT2.
SGLT2 transporters act like a revolving door: they capture filtered glucose and return it to circulation before it can be excreted in urine. This is why healthy people do not spill glucose into urine until blood glucose rises above approximately 180 mg/dL — the renal threshold.
This is also the mechanism that pharmaceutical SGLT2 inhibitors (like empagliflozin, dapagliflozin, and canagliflozin) exploit — by blocking these transporters, they force more glucose to exit via urine, lowering blood glucose. These are serious prescription medications with meaningful clinical benefit and meaningful side effects (UTI risk, ketoacidosis risk at high doses).
What GlucoBerry Claims About This Pathway
GlucoBerry’s Blood Sugar Drain concept proposes that the kidney’s glucose-filtering pathway can become less efficient over time — the formula uses the metaphor of a drain becoming “clogged.” The claim is that Maqui Berry Extract (Delphinol) helps maintain the health and efficiency of this filtering pathway, supporting more complete glucose excretion.
This is a plausible hypothesis. Chronic hyperglycemia is associated with renal tubular dysfunction, and oxidative stress in renal tissue is a well-documented pathway in early diabetic nephropathy. Anthocyanins — the polyphenol class that Delphinol concentrates from Maqui Berry — have demonstrated renal-protective and antioxidant effects in preclinical studies.
Where the Evidence Stands (Honest Assessment)
Here is what the science actually supports as of early 2026:
- Delphinol (Maqui Berry Extract) has a published RCT showing reduced fasting glucose and postprandial glucose in overweight adults. The mechanism in that study is attributed to alpha-glucosidase inhibition (reducing intestinal glucose absorption) and antioxidant activity — not directly to SGLT2 pathway modification. The renal-drain mechanism is a theoretical extrapolation, not directly measured in human trials.
- No published human trial has directly measured Delphinol’s effect on renal glucose excretion via SGLT2 pathways.
- The metaphor is compelling marketing that is built on real physiology — but the specific link between Delphinol and SGLT2-pathway optimization in humans has not been established in peer-reviewed literature.
This does not mean GlucoBerry’s ingredients are ineffective. It means the specific Blood Sugar Drain mechanism, as marketed, is an aspirational extrapolation from plausible science — not a proven causal chain. The ingredient evidence for blood sugar support, taken on its own terms, is meaningful. The marketing wrapper around that evidence is more aggressive than the data strictly supports.
3. The Science: Ingredient Evidence for Blood Sugar Support
Let me take each ingredient in turn and tell you what the human clinical evidence actually shows.
Maqui Berry Extract (Delphinol®)
Delphinol is a standardized extract of Aristotelia chilensis (Maqui Berry), concentrated for delphinidins — a specific anthocyanin subclass with notable biological activity.
The key human trial was published in the journal Nutrients in 2015 — PMID 26471215. In this 120-day double-blind RCT of overweight adults with mildly elevated fasting glucose:
- Fasting plasma glucose decreased by 5.3% in the Delphinol group vs. placebo
- Postprandial glucose (post-meal peak) was also significantly reduced
- Fasting insulin levels dropped by 10.6%, suggesting improved insulin sensitivity
- No adverse effects were reported
The dose used in that trial: 180 mg/day of standardized Delphinol. GlucoBerry’s exact Delphinol dose is not disclosed on the label, which is a transparency limitation worth noting. The clinical range is 90–360 mg/day across studies.
The primary mechanisms identified: alpha-glucosidase inhibition (slowing intestinal carbohydrate breakdown and glucose absorption) and antioxidant activity reducing oxidative stress in glucose metabolism pathways.
Gymnema Sylvestre
Gymnema Sylvestre is one of the most studied blood sugar herbs in Ayurvedic medicine, with a substantial body of modern clinical evidence.
The 2013 meta-analysis published in the Journal of Ethnopharmacology is the most comprehensive systematic review available. Across 11 clinical trials:
- Gymnema consistently reduced fasting blood glucose in pre-diabetic and early T2DM populations
- HbA1c reductions of 0.5–1.0 percentage points were observed in longer-duration trials
- Post-meal glucose responses were attenuated — attributed to gymnemic acid’s structural similarity to glucose molecules, which allows it to block intestinal glucose transporters competitively
Gymnema also has evidence for a direct pancreatic effect: studies suggest it may support beta-cell function and insulin secretion. This dual mechanism — reducing intestinal absorption AND supporting the pancreas’s response — makes it one of the more mechanistically complete botanical glucose-support ingredients available.
Clinical dose range: 200–800 mg/day of standardized extract. Standard GS4 extract is most common in research.
Important safety note: Gymnema’s blood-sugar-lowering activity is additive with diabetes medications. Anyone on metformin, sulfonylureas, or insulin who takes Gymnema at therapeutic doses risks hypoglycemia. This is not a theoretical risk — it is documented in clinical pharmacology literature.
Chromium (as Chromium Picolinate)
Chromium is an essential trace mineral that functions as a cofactor for insulin signaling. It is involved in the translocation of GLUT4 glucose transporters to cell membranes — a step critical for cells to uptake glucose in response to insulin.
The 2015 meta-analysis in Diabetes Technology & Therapeutics reviewed 53 randomized controlled trials of chromium supplementation. Key findings:
- Chromium significantly reduced fasting blood glucose in people with impaired glucose tolerance and T2DM
- Fasting insulin was reduced, suggesting improved insulin sensitivity
- Effect sizes were meaningful but moderate — chromium is a supportive nutrient, not a potent glucose-lowering agent
Chromium deficiency is surprisingly common in Western diets. Processed foods deplete chromium; refined carbohydrates consume chromium in their metabolism. Adults eating high-carbohydrate processed diets may have suboptimal chromium status — and supplementation in this context may restore normal insulin signaling efficiency.
GlucoBerry includes chromium at a dose aligned with the clinical literature. This is one of the more straightforward ingredient choices in the formula.
The Ingredient Stack in Summary
| Ingredient | Key Evidence | Mechanism | Clinical Dose Range |
|---|---|---|---|
| Maqui Berry (Delphinol®) | 120-day RCT: 5.3% fasting glucose reduction | Alpha-glucosidase inhibition, antioxidant | 90–360 mg/day |
| Gymnema Sylvestre | Meta-analysis: HbA1c −0.5 to −1.0% | Intestinal absorption block, beta-cell support | 200–800 mg/day |
| Chromium Picolinate | Meta-analysis (53 RCTs): reduced fasting glucose & insulin | Insulin cofactor, GLUT4 translocation | 200–1,000 mcg/day |
For a complete breakdown of the formula with dosing specifics and safety analysis, see our detailed GlucoBerry ingredients and side effects guide.
4. Who Is GlucoBerry Best Suited For?
This is the most important section in the article. GlucoBerry is not a universal supplement — it has a specific ideal user profile. Let me describe the three groups who are most likely to benefit.
Group 1: Pre-Diabetic Adults (Fasting Glucose 100–125 mg/dL)
Pre-diabetes affects an estimated 96 million American adults, and the majority do not know they have it. A fasting glucose between 100 and 125 mg/dL, or an HbA1c between 5.7% and 6.4%, indicates impaired fasting glucose — blood sugar is elevated but not yet in the diabetic range.
This is the primary population that GlucoBerry’s ingredient profile targets. The Delphinol RCT was conducted in adults with mildly elevated fasting glucose; the Gymnema meta-analysis includes a pre-diabetic subgroup with meaningful effect sizes. Chromium’s insulin-sensitizing effects are most clinically relevant in people with impaired insulin signaling — which is the physiological hallmark of pre-diabetes.
For a pre-diabetic adult managing glucose through diet and exercise, GlucoBerry may provide an evidence-supported additional tool. The 180-day guarantee allows sufficient time to assess whether the supplement produces measurable changes in fasting glucose or HbA1c alongside lifestyle interventions.
Group 2: People with Post-Meal Blood Sugar Spikes
Post-meal (postprandial) glucose spikes are increasingly recognized as a major driver of metabolic dysfunction — even in people whose fasting glucose tests as normal. A continuous glucose monitor (CGM) often reveals that people with “normal” fasting glucose can spike to 160–180 mg/dL after a high-carbohydrate meal, triggering insulin surges, energy crashes, and — over time — progressive insulin resistance.
Both Gymnema Sylvestre and Maqui Berry have specific evidence for reducing postprandial glucose:
- Gymnemic acids block intestinal glucose transporters, physically reducing how much glucose enters the bloodstream from a meal
- Maqui Berry anthocyanins inhibit alpha-glucosidase, slowing starch breakdown and glucose absorption rate
For people who experience the classic post-meal pattern — energy crash 90–120 minutes after eating, sugar cravings in the mid-afternoon, difficulty staying mentally sharp after lunch — GlucoBerry’s ingredient profile targets the upstream mechanism.
Group 3: People with Sugar Cravings Tied to Glucose Dysregulation
This one is less obvious but clinically meaningful. Intense sugar cravings are often a downstream symptom of blood glucose dysregulation. Here’s the physiological cascade: rapid postprandial glucose spike → large insulin release → rapid glucose drop → hunger hormone surge (ghrelin) → intense craving for quick-energy carbohydrates. This cycle repeats and intensifies over time.
Gymnema Sylvestre has a unique additional property: gymnemic acids block sweet taste receptors on the tongue, reducing the perceived sweetness of sugar. This is not a psychological trick — it is a temporary physiological effect. Some people using Gymnema find that desserts and sweet foods lose their appeal, making it easier to reduce sugar intake behaviorally.
By both attenuating the postprandial glucose spike (reducing the subsequent crash and craving) and blunting sweet taste perception, Gymnema addresses sugar cravings through two complementary pathways. This makes GlucoBerry a potentially useful supplement for people trying to break a sugar habit alongside dietary changes.
Try GlucoBerry for Blood Sugar — 180-Day Money-Back Guarantee{rel=“nofollow sponsored”}
5. Who Should NOT Use GlucoBerry for Blood Sugar
Honesty about disqualifying criteria is as important as explaining who benefits. The following groups should either avoid GlucoBerry entirely or use it only under close physician supervision.
People with Type 1 Diabetes
Type 1 diabetes is an autoimmune condition involving the destruction of insulin-producing beta cells. The body produces no — or virtually no — endogenous insulin. Management requires exogenous insulin, continuous glucose monitoring, and careful carbohydrate management.
GlucoBerry’s mechanisms (reducing glucose absorption, improving insulin sensitivity, supporting renal glucose handling) are entirely secondary to the core problem in Type 1: the absence of insulin production. No supplement addresses this fundamental mechanism. Using GlucoBerry as a supplement strategy for Type 1 blood sugar control is inappropriate. Insulin dosing decisions must remain with the treating endocrinologist.
People with Diagnosed Type 2 Diabetes on Medication
This is the most important safety consideration. Gymnema Sylvestre has clinically documented additive effects with:
- Metformin — Gymnema may enhance glucose-lowering, raising hypoglycemia risk
- Sulfonylureas (glipizide, glimepiride, glyburide) — these already stimulate insulin secretion; adding Gymnema’s pancreatic effects can cause significant hypoglycemia
- Insulin — any agent reducing glucose absorption or enhancing insulin sensitivity in an insulin-treated patient requires dosing recalibration
If you are on any of these medications, do not add GlucoBerry without explicit consultation with your prescribing physician. The interaction is not theoretical — Gymnema Sylvestre is potent enough at therapeutic doses to meaningfully alter blood glucose, and stacking it with glucose-lowering medications without medical oversight is genuinely risky.
People Expecting Medication-Level Results
GlucoBerry is a dietary supplement. Its effect sizes — where measurable — are in the range of 5–10% reductions in fasting glucose and 0.5–1.0 percentage point reductions in HbA1c over months of use. Metformin, by comparison, typically reduces HbA1c by 1.0–2.0 percentage points. GLP-1 agonists can reduce HbA1c by 1.5–2.5 percentage points.
If your blood sugar is high enough to require medication — fasting glucose consistently above 126 mg/dL, or HbA1c above 6.4% — you need medical evaluation and likely medication. GlucoBerry is not appropriate as a substitute for that care. The 180-day guarantee is generous, but no guarantee changes the clinical reality that untreated diabetes causes progressive, irreversible complications.
See our GlucoBerry scam or legit analysis for a full assessment of the product’s credibility, evidence quality, and where it sits on the spectrum between legitimate supplement and overpromising marketing.
6. GlucoBerry vs Other Blood Sugar Supplements
GlucoBerry occupies a specific position in the blood sugar supplement market. Understanding how it compares to alternatives helps clarify whether it is the right choice.
GlucoBerry vs. Berberine
Berberine is one of the most evidence-backed natural compounds for blood sugar support. In meta-analyses, berberine has shown HbA1c reductions comparable to metformin in some populations — a finding that has attracted significant clinical interest. If you want the most evidence-dense botanical option for blood sugar, berberine often tops the list.
GlucoBerry’s advantage over berberine: Gymnema’s sweet-taste-blocking property and Delphinol’s specific antioxidant profile are not replicated by berberine. GlucoBerry may be preferable for people who experience significant sugar cravings or want the renal-support angle. For a detailed breakdown of berberine’s evidence base, see our berberine for blood sugar guide.
GlucoBerry vs. Sugar Defender
Sugar Defender is another ClickBank blood sugar supplement with a different ingredient profile — it includes Eleuthero, Coleus Forskohlii, Maca Root, and African Mango alongside glucose-focused ingredients. Sugar Defender takes a more metabolic/energy-focused angle compared to GlucoBerry’s more targeted glucose-mechanism approach. See our Sugar Defender review for the full comparison.
GlucoBerry vs. GlucoTrust
GlucoTrust leans heavily on sleep and cortisol reduction as indirect pathways to blood sugar support (chromium, cinnamon, licorice root, biotin). This is a legitimate metabolic angle — poor sleep genuinely impairs insulin sensitivity. GlucoBerry’s approach is more direct, targeting glucose absorption and renal handling rather than sleep-mediated cortisol pathways. See our GlucoTrust review for the ingredient deep-dive.
GlucoBerry’s Differentiated Position
GlucoBerry’s most distinctive element is the Delphinol inclusion. Maqui Berry Extract is not common in the blood sugar supplement market — most formulas use berberine, cinnamon, bitter melon, or alpha-lipoic acid. Delphinol has published human evidence and a specific standardization that sets it apart. For people who have already tried the standard botanical approaches and want something with a different mechanism, GlucoBerry’s formula is genuinely differentiated.
For a comprehensive look at which ingredients have the strongest evidence base, see our best blood sugar supplement ingredients guide.
Experience GlucoBerry for Yourself — 180-Day Money-Back Guarantee{rel=“nofollow sponsored”}
7. Realistic Blood Sugar Outcomes: What to Expect
Setting accurate expectations is core to my role as a dietitian. Here is what the evidence — not the marketing — suggests you can realistically expect from GlucoBerry.
Timeline
Blood sugar changes take time. HbA1c reflects average blood glucose over approximately 90 days, so meaningful HbA1c shifts require at least 90 days of consistent use. Fasting glucose is more responsive and may show changes within 4–8 weeks.
The Delphinol RCT ran for 120 days, showing progressive improvement over that period. The Gymnema meta-analysis includes trials ranging from 8 weeks to 18 months, with larger effects at longer durations. GlucoBerry’s 180-day guarantee is appropriately sized for a supplement where meaningful effects emerge over months, not weeks.
Expected Magnitude
If GlucoBerry works as the evidence base for its ingredients suggests, a pre-diabetic adult might expect:
- Fasting glucose: 5–10 mg/dL reduction over 90–120 days (from a baseline of 110–120 mg/dL, this is clinically meaningful)
- Postprandial glucose spikes: Noticeably attenuated, particularly after high-carbohydrate meals
- HbA1c: 0.3–0.7 percentage point reduction over 90–120 days (from a baseline of 5.8–6.2%, this may move the needle toward normal range)
- Sugar cravings: Often reported as reduced within the first 2–4 weeks — Gymnema’s sweet taste blunting effect is relatively fast-acting
These are not guaranteed outcomes. Individual response varies based on baseline metabolic status, diet quality, activity level, sleep, and stress. The supplement works best as a complement to meaningful lifestyle change — not as a replacement for it.
What Won’t Change
GlucoBerry will not:
- Reverse established insulin resistance in 30 days
- Produce clinically significant weight loss on its own
- Normalize HbA1c from 7.0% to 5.5% in any reasonable timeframe
- Eliminate the need for diabetes medications if you are already at a level requiring medical management
How to Monitor Progress
If you decide to trial GlucoBerry, I recommend:
- Baseline testing: Get a fasting glucose and HbA1c before starting
- Home glucose monitoring: A basic glucometer allows you to track fasting glucose and postprandial spikes at home — this gives you real data rather than waiting 90 days for a lab result
- Symptom tracking: Note energy levels, afternoon sugar cravings, and post-meal energy crashes — these often shift before lab values do
- 90-day retest: At 90 days, retest fasting glucose and HbA1c to assess response
For what other users report experiencing, see our GlucoBerry real customer reviews compilation.
Visit GlucoBerry Official Website — Risk-Free with 180-Day Money-Back Guarantee{rel=“nofollow sponsored”}
8. Frequently Asked Questions
Is GlucoBerry effective for blood sugar support?
GlucoBerry’s ingredients have published evidence for blood sugar support, particularly Maqui Berry Extract (Delphinol®) — which reduced fasting glucose by 5.3% in a 120-day RCT — and Gymnema Sylvestre, with robust meta-analytic support for reducing HbA1c and fasting glucose. The formula is most effective for pre-diabetic adults and those with mildly elevated fasting glucose (100–125 mg/dL). See our detailed analysis in the full GlucoBerry review.
What is the Blood Sugar Drain mechanism in GlucoBerry?
GlucoBerry’s Blood Sugar Drain concept refers to the kidneys’ natural glucose-filtering mechanism. The kidneys process roughly 160 grams of glucose daily — normally reabsorbed via SGLT2 transporters. GlucoBerry claims that Maqui Berry (Delphinol) supports the health of this filtering pathway, reducing the “stickiness” that may impede efficient glucose excretion. This mechanism is plausible physiology, though direct human evidence for the specific SGLT pathway effect of Delphinol is still emerging.
Can GlucoBerry help with post-meal blood sugar spikes?
Gymnema Sylvestre and Maqui Berry both have evidence for reducing postprandial glucose spikes. Gymnema reduces intestinal glucose absorption via gymnemic acid’s alpha-glucosidase inhibition. Maqui Berry anthocyanins also inhibit intestinal alpha-glucosidase and may reduce glucose absorption. GlucoBerry may support more stable postprandial glucose, particularly when taken before meals.
Is GlucoBerry appropriate for people with Type 2 diabetes?
People with diagnosed Type 2 diabetes on medication should NOT take GlucoBerry without physician oversight. Gymnema Sylvestre can enhance blood-sugar-lowering effects of diabetes medications, creating hypoglycemia risk. GlucoBerry is appropriate as a supporting tool for pre-diabetic individuals or those managing blood sugar through lifestyle alone — not as a replacement for prescribed therapy.
How does GlucoBerry compare to metformin for blood sugar?
GlucoBerry cannot be compared to metformin — they are fundamentally different categories. Metformin is a prescription medication with decades of evidence, approved to treat Type 2 diabetes. GlucoBerry is a dietary supplement for blood sugar support in people below the diabetic threshold. Using GlucoBerry instead of metformin when prescribed is dangerous. Using it before reaching the point of needing medication — as a preventive support tool — is the appropriate context.
When should I take GlucoBerry for blood sugar?
The vendor recommends taking GlucoBerry once daily. Given Gymnema’s mechanism — blocking intestinal glucose absorption — taking it before meals may optimize postprandial glucose control. However, the product’s marketing does not specify meal timing. Follow the label instructions and consult a healthcare provider for personalized guidance.
What blood sugar level is GlucoBerry designed for?
GlucoBerry is designed for adults with mildly elevated blood sugar in the pre-diabetic range (fasting glucose 100–125 mg/dL, or HbA1c 5.7–6.4%) or those with normal-but-fluctuating blood sugar who experience significant post-meal spikes or sugar cravings. It is not designed for people with fasting glucose above 125 mg/dL or Type 1 or Type 2 diabetes requiring medication.
Where can I buy GlucoBerry and what does it cost?
GlucoBerry is sold exclusively through its official website. It is not available on Amazon or in retail stores. Pricing tiers and current discounts are covered in our GlucoBerry pricing and discount guide. All purchases come with a 180-day money-back guarantee.
Check Current GlucoBerry Pricing — 180-Day Risk-Free Guarantee{rel=“nofollow sponsored”}
Final Note on Credentials and Perspective
My analysis of GlucoBerry is based on the published clinical evidence for its ingredients, not on paid partnership or any financial incentive to recommend it. Learn more about my methodology and credentials on the about page.
Where the evidence supports the marketing claims, I say so. Where the marketing extends beyond what the science directly proves — as with the specific SGLT2-pathway mechanism — I say that too. The goal is to give you information accurate enough to have a productive conversation with your own healthcare provider about whether GlucoBerry is appropriate for your situation.
If you are in the pre-diabetic range, managing glucose through lifestyle, and looking for an evidence-supported supplement to complement those efforts, GlucoBerry’s ingredient profile is worth serious consideration. The 180-day guarantee removes the financial risk of trialing it — and it gives you enough time to actually measure whether your fasting glucose or postprandial patterns respond.
Get GlucoBerry Now — Risk-Free with 180-Day Money-Back Guarantee{rel=“nofollow sponsored”}
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult a qualified healthcare provider before starting any supplement regimen.